Medical Device News
@FierceMedDev: IPOs: Sientra goes for $75M, while Nevro nerves up for $100M. Report | Follow @FierceMedDev
@VarunSaxena2: Here's my pernicious article. Read it are your own risk. ICYMI yesterday | Follow @VarunSaxena2
@EmilyWFierce: Find out which companies struck gold in the pharma M&A frenzy in FiercePharma's latest special report. Report | Follow @EmilyWFierce
> Ortho-Clinical Diagnostics, makers of in vitro diagnostic products, received a CE mark for the Ortho Vision Analyzer, an interactive and fully automated analyzer for transfusion medicine laboratories. Release
> Covidien ($COV) launched ReliaTack, a laparoscopic hernia repair device with 65-degree articulation that provides surgeons with greater access to weak spots within the abdominal wall. Release
> Teleflex, a medical device company concentrating on critical care and surgery, was awarded $2.1 million in a research grant from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC) to develop an anti-biofilm medical device. Release
> Leica Biosystems, an anatomical pathology solutions and cancer diagnostics company within Danaher ($DHR), signed an agreement to acquire Devicor, a breast biopsy procedures device player. Release
Biotech News
@FierceBiotech: $AMGN, $SNY and Ono band together for open-source R&D. Article | Follow @FierceBiotech
@JohnCFierce: Amgen adds up to 1,100 new job cuts to its global restructuring plan - Wall Street loves it, shares up 5%. News | Follow @JohnCFierce
@DamianFierce: $RNA CEO on $SRPT's setback: "We are all in this together." More from CNBC | Follow @DamianFierce
@EmilyMFierce: Salk's 100th: Anti-Vaccination Would Trouble Polio Hero. More from LiveScience | Follow @EmilyMFierce
> Novartis chief Jimenez predicts 'multi-blockbuster' success for star heart drug. Article
> Advent joins the parade of new biotech funds with $235M war chest. Item
> Receptos' lead drug scores another promising PhII--this time for ulcerative colitis. News
> Bristol-Myers nabs a HER2 cancer drug in $475M option deal with F-star. Report
Pharma News
@FiercePharma: Tops in FierceAnimalHealth: Lilly divests U.S. animal health assets to Virbac ahead of Novartis deal. Story | Follow @FiercePharma
@EricPFierce: Ranbaxy's New Jersey plant comes through for drugmaker. More | Follow @EricPFierce
@CarlyHFierce: Our newest special report is live! Pharma's top 10 M&A deals of H1 2014. Feature | Follow @CarlyHFierce
> Big relief for Lilly, Boehringer as judge slashes $9B Actos award by 99%. Report
> Pfizer beats the Street's Q3 expectations but stays mum on AZ deal. Article
> Novartis gets 4% sales lift as 'growth products' make good on their label. Story
> Looming trouble in Sanofi's diabetes biz turns up the heat on CEO. More
Biotech Research News
> Government halts research on dangerous airborne pathogens. Item
> Toxin-producing stem cells designed to kill brain cell tumors. Report
> Brain cells reprogrammed from skin cells offer treatment hope for Huntington's. Story
> Case Western, Janssen, Oncodesign scientists ID anti-inflammatory compounds. More
> Protein discovery could help kill stubborn latent HIV. Article
Pharma Manufacturing News
> Australia's CSL gets three Novartis vaccine plants in $275M deal. News
> Ranbaxy's New Jersey plant comes through for drugmaker. Item
> Hikma gets FDA warning letter for plant in Portugal. More
> Fujifilm adding Texas-based vaccine specialist to its fold. Story
> U.S. Attorney subpoenas Novo for info on Denmark plant. Article